Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for (S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMIN ZUR BEHANDLUNG, VORBEUGUNG UND/ODER BEWÄLTIGUNG EINER NEUROLOGISCHEN UND/ODER PSYCHIATRISCHEN STÖRUNG
Details for 2021723520
Up to date per 10.06.2026
Actions
Details for 2021723520
Title / Product Name
(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMIN ZUR BEHANDLUNG, VORBEUGUNG UND/ODER BEWÄLTIGUNG EINER NEUROLOGISCHEN UND/ODER PSYCHIATRISCHEN STÖRUNG
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2021723520
EP Publication Number
4135690
E-Number
1900822
Language
EN
PCT Number
US21026953
Publication Date
22.02.2023 A
25.03.2026 B1
Registration Date
25.03.2026
AT Publication Date
15.04.2026
Application Date
13.04.2021
Registration Number
-
Priorities
14.04.2020
US
202063009595 P
16.06.2020
US
202063039722 P
IPC
A61K 31/381 20060101AFI20211022BHEP
Maximum Duration of Protection
13.04.2041
Owner
Sumitomo Pharma America, Inc.84 Waterford Drive Marlborough, MA 01752US